Showing results (541-550 of 701) with videos related to

Sort By:
Pageof 71
Diabetes|November 22, 2023
Increased Subclinical Coronary Artery Pathology in Type 2 Diabetes With AlbuminuriaIda Kirstine Bull Rasmussen, Anne-Cathrine Skriver-Moeller, Rasmus Sejersten Ripa, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 18, 2023
The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney diseasePeter Rossing, Florian M M Baeres, George Bakris, et al.
American Journal of Nephrology|January 17, 2015
Rationale, design, and baseline characteristics of ARTS-DN: a randomized study to assess the safety and efficacy of finerenone in patients with type 2 diabetes mellitus and a clinical diagnosis of diabetic nephropathyLuis M Ruilope, Rajiv Agarwal, Juliana C Chan, et al.
Diabetologia|September 23, 2022
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Melanie J Davies, Vanita R Aroda, Billy S Collins, et al.
Diabetologia|September 5, 2020
Gut microbiota profile and selected plasma metabolites in type 1 diabetes without and with stratification by albuminuriaSigne A Winther, Peter Henriksen, Josef K Vogt, et al.
Journal of Diabetes and Its Complications|May 15, 2024
Extracellular matrix turnover proteins as risk markers in people with type 2 diabetes and microalbuminuriaAnne-Cathrine Skriver-Møller, Alexandra L Møller, Martin B Blond, et al.
Diabetes, Obesity & Metabolism|July 4, 2023
The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the FIDELITY studyPeter Rossing, Stefan D Anker, Gerasimos Filippatos, et al.
Lipids in Health and Disease|September 26, 2023
Ceramides are decreased after liraglutide treatment in people with type 2 diabetes: a post hoc analysis of two randomized clinical trialsAsger Wretlind, Viktor Rotbain Curovic, Andressa de Zawadzki, et al.
Kidney International Reports|June 15, 2026
Post-Hoc Analysis on the Effects of Vicadrostat/Empagliflozin by CKD Severity/Hypertension StatusRicardo Correa-Rotter, Peter Rossing, Maria Eugenia Canziani, et al.
Kidney International|August 5, 2019
Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney diseasePeter Rossing, Geoffrey A Block, Melanie P Chin, et al.
Pageof 71